“It’s a dream come true.It may sound corny, but iRep is doing everything we want it to do and then some.”

“We use Vault reports to perform preinspection quality control (QC). The ability to generate a report showing all unblinded study documents enables us to quickly review content and minimize stress.”

“Having one platform allows you to not only see what other groups are doing, but to have one authoritative truth.”

"With Veeva OpenData and Veeva Nitro, we have a strong data infrastructure that provides us with robust insights and analytics for launch and beyond."

"Our vision was to create a unified, dynamic, and automated platform that will drive us toward a future where training is seamless, efficient, and accessible to everybody."

“Our strategic partnership with Veeva expands our capacity to leverage innovative technology and enhances our ability to deliver value to patients and all our stakeholders.”

“We’re seeing a lot of enthusiasm for Site Connect — with faster start-up times and improved visibility and transparency through the trial process.”

"We see up to 50% faster build times with Veeva CDMS."

“AI in pharma content review has officially crossed the line from interesting concept to strategic priority.”

“We moved fast. It was ambitious and an outstanding example for great teamwork. Now we can continue with full focus to enable an AI powered next generation customer engagement model to serve our customers and patients.”

“Our clinical team was very excited because they handle the fallout when principal investigators or site users are not able to access a training or completing the signatures."

“If somebody is looking for safety information, the place to go is the Safety Vault, not on SharePoint or on another platform. Any department that needs safety data knows that the data is in the Safety Vault, and the data can be shared and transferred easily. They also have better …

“The retention and consolidation of feasibility data within Veeva allows us to mine the data. We can establish correlations between what a site said it could contribute to a study and the actual contributions it ends up making, enabling improved feedback loops to drive site selection decision-making.”

“By using Veeva Study Startup, we’ve reduced the overall timeline from site selection to site activation by 33%. And we shaved off six weeks from the time the protocol is approved to when the first subject is dosed."

“In the beginning, we met as five different Vaults. That prevented us from clearly articulating which updates were important to business partners.”